Roivant Sciences Ltd. (ROIV)
35.72
+0.22
(+0.62%)
USD |
NASDAQ |
Oct 02, 16:00
35.68
-0.04
(-0.11%)
After-Hours: 20:00
Roivant Sciences Market Cap : 25.81B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 25.81B |
| October 01, 2026 | 25.65B |
| September 30, 2026 | 26.43B |
| September 29, 2026 | 26.38B |
| September 28, 2026 | 26.72B |
| September 25, 2026 | 25.87B |
| September 24, 2026 | 26.11B |
| September 23, 2026 | 26.61B |
| September 22, 2026 | 27.62B |
| September 21, 2026 | 28.18B |
| September 18, 2026 | 28.74B |
| September 17, 2026 | 28.89B |
| September 16, 2026 | 28.60B |
| September 15, 2026 | 28.55B |
| September 14, 2026 | 29.64B |
| September 11, 2026 | 29.50B |
| September 10, 2026 | 29.59B |
| September 09, 2026 | 30.21B |
| September 08, 2026 | 29.98B |
| September 04, 2026 | 25.24B |
| September 03, 2026 | 24.87B |
| September 02, 2026 | 24.70B |
| September 01, 2026 | 24.95B |
| August 31, 2026 | 25.03B |
| August 28, 2026 | 25.08B |
| Date | Value |
|---|---|
| August 27, 2026 | 27.16B |
| August 26, 2026 | 26.56B |
| August 25, 2026 | 26.36B |
| August 24, 2026 | 26.28B |
| August 21, 2026 | 26.23B |
| August 20, 2026 | 26.62B |
| August 19, 2026 | 27.03B |
| August 18, 2026 | 27.01B |
| August 17, 2026 | 26.19B |
| August 14, 2026 | 26.16B |
| August 13, 2026 | 26.22B |
| August 12, 2026 | 26.13B |
| August 11, 2026 | 25.47B |
| August 10, 2026 | 25.86B |
| August 07, 2026 | 26.26B |
| August 06, 2026 | 25.38B |
| August 05, 2026 | 25.00B |
| August 04, 2026 | 25.00B |
| August 03, 2026 | 24.00B |
| July 31, 2026 | 24.43B |
| July 30, 2026 | 24.87B |
| July 29, 2026 | 23.68B |
| July 28, 2026 | 24.38B |
| July 27, 2026 | 25.01B |
| July 24, 2026 | 25.22B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oxford Biomedica Plc | 866.65M |
| Bicycle Therapeutics Plc | 170.27M |
| Arbutus Biopharma Corp. | 879.47M |
| Adaptimmune Therapeutics Plc | 9.807M |
| Kiniksa Pharmaceuticals International Plc | 5.910B |
Market Cap Related Metrics
| PS Ratio | 3451.15 |
| Price to Book Value | 6.101 |
| Price | 35.72 |
| Earnings Yield | -1.23% |